CD5 positive follicular lymphomas: A diagnostic dilemma in a resource restricted laboratory setting

Authors

  • Sakthi Sankari Shanmuga Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamilnadu, India, 641004
  • Arjunan Angaraju Department of Pathology, Coimbatore Medical college, Coimbatore, Tamilnadu, India
  • Bhuvaneswari M Ganesan Department of Pathology, Coimbatore Medical college, Coimbatore, Tamilnadu, India
  • Sindhuja Ramalingam Department of Pathology, Thirunelveli Medical college, Tamilnadu, India
  • Rajeswari Thivya Dhanabalan Department of Pathology, Karpaga Vinayaga Medical College, Kanchipuram, Tamilnadu, India

Keywords:

Follicular lymphoma, CD 5 positive, indolent lymphomas, B cell NHL, Immunohistochemistry

Abstract

Background: Follicular lymphoma is an indolent B Non Hodgkin lymphoma which has a characteristic follicular growth pattern and immunohistochemical expression. The neoplastic cells express CD20, CD10, BCL2 and are negative for CD5, CD23 and Cyclin D1. CD5 is a useful marker in the differentiation of various B cell lymphomas. Small cell lymphoma and mantle cell lymphoma express CD5. Some of the follicular lymphomas  express CD5 which results in diagnostic confusion.

Methods: 52 cases of lymphoma were diagnosed over a period of 2 years in a tertiary care centre in south India. Among these, 9 cases were diagnosed as follicular lymphoma based on the morphological abd immunohistochemical study. A panel of antibodies were chosen based on the morphological diagnosis.The panel used for small cell lymphomas include  CD20, CD3, CD5 CD23, Cyclin D1, CD10, BCL2 and Ki67.

Result: Of the nine cases of follicular lymphoma, three were CD5 positive. Two showed bone marrow involvement. There was no significant morphological difference between CD5 positive and CD5 negative follicular lymphoma.

Conclusion: The expression of CD5 by follicular lymphomas  could be problematic when the follicular lymphoma as such lacks its characteristic follicular pattern and there are no molecular studies available. Eventhough rare , follicular lymphoma is to be considered in the differential diagnosis of CD5 positive follicular lymphomas.

 

DOI: 10.21276/APALM.1364

Author Biography

Sakthi Sankari Shanmuga, Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamilnadu, India, 641004

Pathology, Assistant Professor

References

1 Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J,Vardiman JW (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008; 220–226.
2. Horsman DE, Gascoyne RD, Coupland RW et al. Comparison of cytogenetic analysis, southern analysis,and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol 1995; 103:472–478
3. Stamatopoulos K, Kosmas C, Belessi C, et al. Molecular insights into the immunopathogenesis of follicular lymphoma. Immunol Today. 2000; 21:298-305.
4. Dogan A, Bagdi E, Munson P, et al. CD10 and bcl-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000; 24:846-852.
5. Dorfman DM, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol. 1997; 10:859–863.
6. Yin CC, Lin P, Carney DA et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005; 123: 594–602.
7. Leon ED, Alkan S, Huang JC, et al. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin’s lymphomas of small lymphocytes. Mod Pathol. 1998; 11:1046-1051.
9. Sundeen JT, Longo DL, Jaffe ES. CD5 expression in B-cell small lymphocytic malignancies: correlations with clinical presentation and sites of disease. Am J Surg Pathol. 1992; 16:130-137.
10. Dong HY, Gorczyca W, Liu Z et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 2003; 119:218–230.
11. Sekiguchi Y, Imai H, Wakabayashi M et al. CD5- positive follicular lymphoma: a case report and literature review. Intern Med. 2011; 50:899–904.
12. Mayson E, Saverimuttu J, Cartwright K. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker? Intern Med J. 2014; 44:417–422.
13. Takata K, Miyata-Takata T, Sato Y, Yoshino T. Pathology of Follicular Lymphoma. J Clin Exp Hematop. 2014; 54(1): 3-9.
14. Fouad-Younes S, Beck A, Lossos IS, et al. Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse
Components. Am J Surg Pathol. 2010; 34(9): 1266–76.
15. Rizzo K, Nassiri M. DiagnosticWorkup of Small B cell Lymphomas: A Laboratory Perspective. Hindawi Publishing Corporation Lymphoma. 2012;
16. Barry TS, Jaffe ES. CD5+ Follicular Lymphoma A Clinicopathologic Study of Three Cases. Am J Clin Pathol 2002; 118:589-598.
17. Yu Li, Shimin Hu, Zhuang Zuo, Ming Hong. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Modern Pathology 2015;28, 787–798.

Downloads

Published

10-12-2017

How to Cite

1.
Shanmuga SS, Angaraju A, Ganesan BM, Ramalingam S, Dhanabalan RT. CD5 positive follicular lymphomas: A diagnostic dilemma in a resource restricted laboratory setting. Ann of Pathol and Lab Med [Internet]. 2017 Dec. 10 [cited 2025 Feb. 5];4(6):A621-625. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1364

Issue

Vol. 4 No. 6 (2017)

Section

Original Article

License

Copyright (c) 2017 Sakthi Sankari Shanmuga, Arjunan Angaraju, Bhuvaneswari M Ganesan, Sindhuja Ramalingam, Rajeswari Thivya Dhanabalan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).